Phase 1 clinical trial for leucettinib-21

Fragile X syndrome and phosphodiesterases Fragile X syndrome (FXS) is the most common form of inherited intellectual disability. It is a rare genetic neurodevelopmental disorder characterised […]

Significant headway has been made in recent years to understand the causes of intellectual disability in people with Down syndrome, but therapeutic research on this syndrome […]